nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitotane—SERPINA6—Triamcinolone—ankylosing spondylitis	0.368	0.417	CbGbCtD
Mitotane—SERPINA6—Prednisolone—ankylosing spondylitis	0.312	0.353	CbGbCtD
Mitotane—CYP11A1—Dexamethasone—ankylosing spondylitis	0.203	0.23	CbGbCtD
Mitotane—Trauma—Betamethasone—ankylosing spondylitis	0.00148	0.0127	CcSEcCtD
Mitotane—Retinal disorder—Methotrexate—ankylosing spondylitis	0.00144	0.0123	CcSEcCtD
Mitotane—Trauma—Prednisone—ankylosing spondylitis	0.00129	0.011	CcSEcCtD
Mitotane—Epigastric discomfort—Prednisone—ankylosing spondylitis	0.00117	0.01	CcSEcCtD
Mitotane—Dermatitis atopic—Prednisolone—ankylosing spondylitis	0.00114	0.00977	CcSEcCtD
Mitotane—Hypertriglyceridaemia—Prednisone—ankylosing spondylitis	0.00107	0.00915	CcSEcCtD
Mitotane—Dermatitis atopic—Triamcinolone—ankylosing spondylitis	0.00105	0.00899	CcSEcCtD
Mitotane—Fungal infection—Methylprednisolone—ankylosing spondylitis	0.001	0.0086	CcSEcCtD
Mitotane—Hypothyroidism—Prednisone—ankylosing spondylitis	0.000957	0.00819	CcSEcCtD
Mitotane—Blood triglycerides increased—Prednisone—ankylosing spondylitis	0.000938	0.00802	CcSEcCtD
Mitotane—Mucosal inflammation—Methotrexate—ankylosing spondylitis	0.000928	0.00794	CcSEcCtD
Mitotane—Fungal infection—Betamethasone—ankylosing spondylitis	0.000914	0.00782	CcSEcCtD
Mitotane—Fungal infection—Dexamethasone—ankylosing spondylitis	0.000914	0.00782	CcSEcCtD
Mitotane—Dermatitis atopic—Prednisone—ankylosing spondylitis	0.00083	0.0071	CcSEcCtD
Mitotane—Cataract—Triamcinolone—ankylosing spondylitis	0.000817	0.00699	CcSEcCtD
Mitotane—Encephalopathy—Methotrexate—ankylosing spondylitis	0.0008	0.00684	CcSEcCtD
Mitotane—Fungal infection—Prednisone—ankylosing spondylitis	0.000796	0.00681	CcSEcCtD
Mitotane—Endocrine disorder—Prednisone—ankylosing spondylitis	0.000741	0.00634	CcSEcCtD
Mitotane—Cataract—Dexamethasone—ankylosing spondylitis	0.000741	0.00634	CcSEcCtD
Mitotane—Cataract—Betamethasone—ankylosing spondylitis	0.000741	0.00634	CcSEcCtD
Mitotane—Injury—Prednisolone—ankylosing spondylitis	0.000668	0.00571	CcSEcCtD
Mitotane—Fungal infection—Methotrexate—ankylosing spondylitis	0.000665	0.00569	CcSEcCtD
Mitotane—Hypercholesterolaemia—Prednisone—ankylosing spondylitis	0.00065	0.00556	CcSEcCtD
Mitotane—Cataract—Prednisone—ankylosing spondylitis	0.000646	0.00552	CcSEcCtD
Mitotane—Injury—Triamcinolone—ankylosing spondylitis	0.000614	0.00525	CcSEcCtD
Mitotane—Osteoarthritis—Prednisolone—ankylosing spondylitis	0.000614	0.00525	CcSEcCtD
Mitotane—Injury—Methylprednisolone—ankylosing spondylitis	0.000613	0.00524	CcSEcCtD
Mitotane—Amnesia—Methylprednisolone—ankylosing spondylitis	0.0006	0.00513	CcSEcCtD
Mitotane—Speech disorder—Methotrexate—ankylosing spondylitis	0.000597	0.00511	CcSEcCtD
Mitotane—Proteinuria—Methotrexate—ankylosing spondylitis	0.000585	0.005	CcSEcCtD
Mitotane—Protein urine present—Methotrexate—ankylosing spondylitis	0.000576	0.00493	CcSEcCtD
Mitotane—Osteoarthritis—Triamcinolone—ankylosing spondylitis	0.000565	0.00483	CcSEcCtD
Mitotane—Osteoarthritis—Methylprednisolone—ankylosing spondylitis	0.000563	0.00482	CcSEcCtD
Mitotane—Injury—Dexamethasone—ankylosing spondylitis	0.000557	0.00477	CcSEcCtD
Mitotane—Injury—Betamethasone—ankylosing spondylitis	0.000557	0.00477	CcSEcCtD
Mitotane—Hepatic enzyme increased—Methotrexate—ankylosing spondylitis	0.000543	0.00465	CcSEcCtD
Mitotane—Dysarthria—Methotrexate—ankylosing spondylitis	0.000543	0.00465	CcSEcCtD
Mitotane—Muscular weakness—Prednisolone—ankylosing spondylitis	0.000541	0.00463	CcSEcCtD
Mitotane—Irritability—Methylprednisolone—ankylosing spondylitis	0.000538	0.0046	CcSEcCtD
Mitotane—Lethargy—Betamethasone—ankylosing spondylitis	0.000523	0.00447	CcSEcCtD
Mitotane—Lethargy—Dexamethasone—ankylosing spondylitis	0.000523	0.00447	CcSEcCtD
Mitotane—Osteoarthritis—Betamethasone—ankylosing spondylitis	0.000512	0.00438	CcSEcCtD
Mitotane—Osteoarthritis—Dexamethasone—ankylosing spondylitis	0.000512	0.00438	CcSEcCtD
Mitotane—Breast disorder—Methylprednisolone—ankylosing spondylitis	0.000509	0.00435	CcSEcCtD
Mitotane—Muscular weakness—Triamcinolone—ankylosing spondylitis	0.000498	0.00426	CcSEcCtD
Mitotane—Muscular weakness—Methylprednisolone—ankylosing spondylitis	0.000497	0.00425	CcSEcCtD
Mitotane—Irritability—Dexamethasone—ankylosing spondylitis	0.000489	0.00418	CcSEcCtD
Mitotane—Irritability—Betamethasone—ankylosing spondylitis	0.000489	0.00418	CcSEcCtD
Mitotane—Injury—Prednisone—ankylosing spondylitis	0.000485	0.00415	CcSEcCtD
Mitotane—Amnesia—Prednisone—ankylosing spondylitis	0.000475	0.00406	CcSEcCtD
Mitotane—Neoplasm—Methotrexate—ankylosing spondylitis	0.000464	0.00397	CcSEcCtD
Mitotane—Gynaecomastia—Methotrexate—ankylosing spondylitis	0.00046	0.00393	CcSEcCtD
Mitotane—Lethargy—Prednisone—ankylosing spondylitis	0.000455	0.00389	CcSEcCtD
Mitotane—Muscular weakness—Betamethasone—ankylosing spondylitis	0.000452	0.00386	CcSEcCtD
Mitotane—Muscular weakness—Dexamethasone—ankylosing spondylitis	0.000452	0.00386	CcSEcCtD
Mitotane—Osteoarthritis—Prednisone—ankylosing spondylitis	0.000446	0.00382	CcSEcCtD
Mitotane—Infestation NOS—Methylprednisolone—ankylosing spondylitis	0.000434	0.00371	CcSEcCtD
Mitotane—Infestation—Methylprednisolone—ankylosing spondylitis	0.000434	0.00371	CcSEcCtD
Mitotane—Irritability—Prednisone—ankylosing spondylitis	0.000426	0.00364	CcSEcCtD
Mitotane—Visual impairment—Prednisolone—ankylosing spondylitis	0.000409	0.0035	CcSEcCtD
Mitotane—Muscular weakness—Prednisone—ankylosing spondylitis	0.000393	0.00337	CcSEcCtD
Mitotane—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.000383	0.00328	CcSEcCtD
Mitotane—Lethargy—Methotrexate—ankylosing spondylitis	0.00038	0.00325	CcSEcCtD
Mitotane—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.000376	0.00321	CcSEcCtD
Mitotane—Osteoarthritis—Methotrexate—ankylosing spondylitis	0.000373	0.00319	CcSEcCtD
Mitotane—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.000364	0.00312	CcSEcCtD
Mitotane—Neutropenia—Prednisone—ankylosing spondylitis	0.000361	0.00308	CcSEcCtD
Mitotane—Irritability—Methotrexate—ankylosing spondylitis	0.000356	0.00304	CcSEcCtD
Mitotane—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.000354	0.00302	CcSEcCtD
Mitotane—Ataxia—Methotrexate—ankylosing spondylitis	0.000351	0.003	CcSEcCtD
Mitotane—Vision blurred—Prednisolone—ankylosing spondylitis	0.000348	0.00298	CcSEcCtD
Mitotane—Visual impairment—Dexamethasone—ankylosing spondylitis	0.000342	0.00292	CcSEcCtD
Mitotane—Visual impairment—Betamethasone—ankylosing spondylitis	0.000342	0.00292	CcSEcCtD
Mitotane—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.000341	0.00292	CcSEcCtD
Mitotane—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.000339	0.0029	CcSEcCtD
Mitotane—Breast disorder—Methotrexate—ankylosing spondylitis	0.000337	0.00288	CcSEcCtD
Mitotane—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.000333	0.00285	CcSEcCtD
Mitotane—Vertigo—Prednisolone—ankylosing spondylitis	0.000332	0.00284	CcSEcCtD
Mitotane—Eye disorder—Betamethasone—ankylosing spondylitis	0.000331	0.00283	CcSEcCtD
Mitotane—Eye disorder—Dexamethasone—ankylosing spondylitis	0.000331	0.00283	CcSEcCtD
Mitotane—Angiopathy—Betamethasone—ankylosing spondylitis	0.000322	0.00275	CcSEcCtD
Mitotane—Angiopathy—Dexamethasone—ankylosing spondylitis	0.000322	0.00275	CcSEcCtD
Mitotane—Hypertension—Prednisolone—ankylosing spondylitis	0.000319	0.00273	CcSEcCtD
Mitotane—Vertigo—Triamcinolone—ankylosing spondylitis	0.000305	0.00261	CcSEcCtD
Mitotane—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000305	0.00261	CcSEcCtD
Mitotane—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000303	0.00259	CcSEcCtD
Mitotane—Neutropenia—Methotrexate—ankylosing spondylitis	0.000301	0.00258	CcSEcCtD
Mitotane—Shock—Prednisolone—ankylosing spondylitis	0.000297	0.00254	CcSEcCtD
Mitotane—Hypertension—Triamcinolone—ankylosing spondylitis	0.000294	0.00251	CcSEcCtD
Mitotane—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000293	0.00251	CcSEcCtD
Mitotane—Eye disorder—Prednisone—ankylosing spondylitis	0.000288	0.00247	CcSEcCtD
Mitotane—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000287	0.00246	CcSEcCtD
Mitotane—Infestation—Methotrexate—ankylosing spondylitis	0.000287	0.00246	CcSEcCtD
Mitotane—Drowsiness—Methotrexate—ankylosing spondylitis	0.000287	0.00246	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000287	0.00245	CcSEcCtD
Mitotane—Flushing—Prednisone—ankylosing spondylitis	0.000286	0.00245	CcSEcCtD
Mitotane—Angiopathy—Prednisone—ankylosing spondylitis	0.00028	0.0024	CcSEcCtD
Mitotane—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000279	0.00239	CcSEcCtD
Mitotane—Vertigo—Betamethasone—ankylosing spondylitis	0.000277	0.00237	CcSEcCtD
Mitotane—Vertigo—Dexamethasone—ankylosing spondylitis	0.000277	0.00237	CcSEcCtD
Mitotane—Infection—Triamcinolone—ankylosing spondylitis	0.000276	0.00236	CcSEcCtD
Mitotane—Infection—Methylprednisolone—ankylosing spondylitis	0.000275	0.00235	CcSEcCtD
Mitotane—Haematuria—Methotrexate—ankylosing spondylitis	0.000274	0.00234	CcSEcCtD
Mitotane—Shock—Triamcinolone—ankylosing spondylitis	0.000273	0.00234	CcSEcCtD
Mitotane—Shock—Methylprednisolone—ankylosing spondylitis	0.000272	0.00233	CcSEcCtD
Mitotane—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000272	0.00232	CcSEcCtD
Mitotane—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000272	0.00232	CcSEcCtD
Mitotane—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000271	0.00232	CcSEcCtD
Mitotane—Mental disorder—Prednisone—ankylosing spondylitis	0.00027	0.00231	CcSEcCtD
Mitotane—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000269	0.0023	CcSEcCtD
Mitotane—Malnutrition—Prednisone—ankylosing spondylitis	0.000269	0.0023	CcSEcCtD
Mitotane—Hypertension—Betamethasone—ankylosing spondylitis	0.000266	0.00228	CcSEcCtD
Mitotane—Hypertension—Dexamethasone—ankylosing spondylitis	0.000266	0.00228	CcSEcCtD
Mitotane—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000259	0.00221	CcSEcCtD
Mitotane—Pain—Prednisolone—ankylosing spondylitis	0.000258	0.00221	CcSEcCtD
Mitotane—Hepatitis—Methotrexate—ankylosing spondylitis	0.000258	0.00221	CcSEcCtD
Mitotane—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000255	0.00218	CcSEcCtD
Mitotane—Vision blurred—Prednisone—ankylosing spondylitis	0.000253	0.00217	CcSEcCtD
Mitotane—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000253	0.00216	CcSEcCtD
Mitotane—Infection—Betamethasone—ankylosing spondylitis	0.00025	0.00214	CcSEcCtD
Mitotane—Infection—Dexamethasone—ankylosing spondylitis	0.00025	0.00214	CcSEcCtD
Mitotane—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000249	0.00213	CcSEcCtD
Mitotane—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000249	0.00213	CcSEcCtD
Mitotane—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000249	0.00213	CcSEcCtD
Mitotane—Visual impairment—Methotrexate—ankylosing spondylitis	0.000249	0.00213	CcSEcCtD
Mitotane—Anaemia—Prednisone—ankylosing spondylitis	0.000248	0.00212	CcSEcCtD
Mitotane—Shock—Betamethasone—ankylosing spondylitis	0.000248	0.00212	CcSEcCtD
Mitotane—Shock—Dexamethasone—ankylosing spondylitis	0.000248	0.00212	CcSEcCtD
Mitotane—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000247	0.00211	CcSEcCtD
Mitotane—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000247	0.00211	CcSEcCtD
Mitotane—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000247	0.00211	CcSEcCtD
Mitotane—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000247	0.00211	CcSEcCtD
Mitotane—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000244	0.00209	CcSEcCtD
Mitotane—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000244	0.00208	CcSEcCtD
Mitotane—Vertigo—Prednisone—ankylosing spondylitis	0.000241	0.00206	CcSEcCtD
Mitotane—Eye disorder—Methotrexate—ankylosing spondylitis	0.000241	0.00206	CcSEcCtD
Mitotane—Anorexia—Betamethasone—ankylosing spondylitis	0.00024	0.00205	CcSEcCtD
Mitotane—Anorexia—Dexamethasone—ankylosing spondylitis	0.00024	0.00205	CcSEcCtD
Mitotane—Pain—Triamcinolone—ankylosing spondylitis	0.000237	0.00203	CcSEcCtD
Mitotane—Hypotension—Betamethasone—ankylosing spondylitis	0.000235	0.00201	CcSEcCtD
Mitotane—Hypotension—Dexamethasone—ankylosing spondylitis	0.000235	0.00201	CcSEcCtD
Mitotane—Angiopathy—Methotrexate—ankylosing spondylitis	0.000234	0.002	CcSEcCtD
Mitotane—Hypertension—Prednisone—ankylosing spondylitis	0.000232	0.00198	CcSEcCtD
Mitotane—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000229	0.00196	CcSEcCtD
Mitotane—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000228	0.00195	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000227	0.00194	CcSEcCtD
Mitotane—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000226	0.00193	CcSEcCtD
Mitotane—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000226	0.00193	CcSEcCtD
Mitotane—Mental disorder—Methotrexate—ankylosing spondylitis	0.000226	0.00193	CcSEcCtD
Mitotane—Malnutrition—Methotrexate—ankylosing spondylitis	0.000225	0.00192	CcSEcCtD
Mitotane—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000222	0.0019	CcSEcCtD
Mitotane—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000222	0.0019	CcSEcCtD
Mitotane—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000222	0.0019	CcSEcCtD
Mitotane—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00022	0.00188	CcSEcCtD
Mitotane—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000219	0.00188	CcSEcCtD
Mitotane—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000219	0.00187	CcSEcCtD
Mitotane—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000219	0.00187	CcSEcCtD
Mitotane—Infection—Prednisone—ankylosing spondylitis	0.000218	0.00186	CcSEcCtD
Mitotane—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000217	0.00186	CcSEcCtD
Mitotane—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000217	0.00186	CcSEcCtD
Mitotane—Shock—Prednisone—ankylosing spondylitis	0.000216	0.00185	CcSEcCtD
Mitotane—Pain—Betamethasone—ankylosing spondylitis	0.000215	0.00184	CcSEcCtD
Mitotane—Pain—Dexamethasone—ankylosing spondylitis	0.000215	0.00184	CcSEcCtD
Mitotane—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000215	0.00184	CcSEcCtD
Mitotane—Skin disorder—Prednisone—ankylosing spondylitis	0.000213	0.00182	CcSEcCtD
Mitotane—Vision blurred—Methotrexate—ankylosing spondylitis	0.000212	0.00181	CcSEcCtD
Mitotane—Anorexia—Prednisone—ankylosing spondylitis	0.000209	0.00179	CcSEcCtD
Mitotane—Anaemia—Methotrexate—ankylosing spondylitis	0.000208	0.00178	CcSEcCtD
Mitotane—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000207	0.00177	CcSEcCtD
Mitotane—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000207	0.00177	CcSEcCtD
Mitotane—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000204	0.00175	CcSEcCtD
Mitotane—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000204	0.00174	CcSEcCtD
Mitotane—Vertigo—Methotrexate—ankylosing spondylitis	0.000202	0.00173	CcSEcCtD
Mitotane—Dizziness—Prednisolone—ankylosing spondylitis	0.0002	0.00171	CcSEcCtD
Mitotane—Asthenia—Triamcinolone—ankylosing spondylitis	0.000199	0.0017	CcSEcCtD
Mitotane—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000199	0.0017	CcSEcCtD
Mitotane—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000199	0.0017	CcSEcCtD
Mitotane—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000199	0.0017	CcSEcCtD
Mitotane—Paraesthesia—Prednisone—ankylosing spondylitis	0.000197	0.00168	CcSEcCtD
Mitotane—Dyspepsia—Prednisone—ankylosing spondylitis	0.000193	0.00165	CcSEcCtD
Mitotane—Decreased appetite—Prednisone—ankylosing spondylitis	0.000191	0.00163	CcSEcCtD
Mitotane—Rash—Prednisolone—ankylosing spondylitis	0.00019	0.00163	CcSEcCtD
Mitotane—Dermatitis—Prednisolone—ankylosing spondylitis	0.00019	0.00163	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00019	0.00162	CcSEcCtD
Mitotane—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000189	0.00162	CcSEcCtD
Mitotane—Headache—Prednisolone—ankylosing spondylitis	0.000189	0.00162	CcSEcCtD
Mitotane—Confusional state—Methotrexate—ankylosing spondylitis	0.000185	0.00158	CcSEcCtD
Mitotane—Dizziness—Triamcinolone—ankylosing spondylitis	0.000183	0.00157	CcSEcCtD
Mitotane—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000183	0.00157	CcSEcCtD
Mitotane—Infection—Methotrexate—ankylosing spondylitis	0.000182	0.00156	CcSEcCtD
Mitotane—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000181	0.00155	CcSEcCtD
Mitotane—Asthenia—Dexamethasone—ankylosing spondylitis	0.000181	0.00155	CcSEcCtD
Mitotane—Asthenia—Betamethasone—ankylosing spondylitis	0.000181	0.00155	CcSEcCtD
Mitotane—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00018	0.00154	CcSEcCtD
Mitotane—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000179	0.00153	CcSEcCtD
Mitotane—Nausea—Prednisolone—ankylosing spondylitis	0.000179	0.00153	CcSEcCtD
Mitotane—Skin disorder—Methotrexate—ankylosing spondylitis	0.000178	0.00152	CcSEcCtD
Mitotane—Vomiting—Triamcinolone—ankylosing spondylitis	0.000176	0.00151	CcSEcCtD
Mitotane—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000176	0.00151	CcSEcCtD
Mitotane—Rash—Triamcinolone—ankylosing spondylitis	0.000175	0.0015	CcSEcCtD
Mitotane—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000175	0.0015	CcSEcCtD
Mitotane—Anorexia—Methotrexate—ankylosing spondylitis	0.000175	0.00149	CcSEcCtD
Mitotane—Rash—Methylprednisolone—ankylosing spondylitis	0.000175	0.00149	CcSEcCtD
Mitotane—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000174	0.00149	CcSEcCtD
Mitotane—Headache—Triamcinolone—ankylosing spondylitis	0.000174	0.00149	CcSEcCtD
Mitotane—Headache—Methylprednisolone—ankylosing spondylitis	0.000173	0.00148	CcSEcCtD
Mitotane—Body temperature increased—Prednisone—ankylosing spondylitis	0.000173	0.00148	CcSEcCtD
Mitotane—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000172	0.00147	CcSEcCtD
Mitotane—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000172	0.00147	CcSEcCtD
Mitotane—Hypotension—Methotrexate—ankylosing spondylitis	0.000171	0.00146	CcSEcCtD
Mitotane—Dizziness—Dexamethasone—ankylosing spondylitis	0.000166	0.00142	CcSEcCtD
Mitotane—Dizziness—Betamethasone—ankylosing spondylitis	0.000166	0.00142	CcSEcCtD
Mitotane—Nausea—Triamcinolone—ankylosing spondylitis	0.000165	0.00141	CcSEcCtD
Mitotane—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000165	0.00141	CcSEcCtD
Mitotane—Nausea—Methylprednisolone—ankylosing spondylitis	0.000164	0.00141	CcSEcCtD
Mitotane—Somnolence—Methotrexate—ankylosing spondylitis	0.000163	0.00139	CcSEcCtD
Mitotane—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000162	0.00138	CcSEcCtD
Mitotane—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000161	0.00138	CcSEcCtD
Mitotane—Vomiting—Dexamethasone—ankylosing spondylitis	0.00016	0.00137	CcSEcCtD
Mitotane—Vomiting—Betamethasone—ankylosing spondylitis	0.00016	0.00137	CcSEcCtD
Mitotane—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000159	0.00136	CcSEcCtD
Mitotane—Rash—Betamethasone—ankylosing spondylitis	0.000159	0.00136	CcSEcCtD
Mitotane—Rash—Dexamethasone—ankylosing spondylitis	0.000159	0.00136	CcSEcCtD
Mitotane—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000159	0.00136	CcSEcCtD
Mitotane—Dermatitis—Betamethasone—ankylosing spondylitis	0.000159	0.00136	CcSEcCtD
Mitotane—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000158	0.00135	CcSEcCtD
Mitotane—Headache—Dexamethasone—ankylosing spondylitis	0.000158	0.00135	CcSEcCtD
Mitotane—Headache—Betamethasone—ankylosing spondylitis	0.000158	0.00135	CcSEcCtD
Mitotane—Asthenia—Prednisone—ankylosing spondylitis	0.000157	0.00135	CcSEcCtD
Mitotane—Pain—Methotrexate—ankylosing spondylitis	0.000157	0.00134	CcSEcCtD
Mitotane—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000151	0.00129	CcSEcCtD
Mitotane—Diarrhoea—Prednisone—ankylosing spondylitis	0.00015	0.00128	CcSEcCtD
Mitotane—Nausea—Betamethasone—ankylosing spondylitis	0.00015	0.00128	CcSEcCtD
Mitotane—Nausea—Dexamethasone—ankylosing spondylitis	0.00015	0.00128	CcSEcCtD
Mitotane—Dizziness—Prednisone—ankylosing spondylitis	0.000145	0.00124	CcSEcCtD
Mitotane—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000145	0.00124	CcSEcCtD
Mitotane—Vomiting—Prednisone—ankylosing spondylitis	0.000139	0.00119	CcSEcCtD
Mitotane—Rash—Prednisone—ankylosing spondylitis	0.000138	0.00118	CcSEcCtD
Mitotane—Dermatitis—Prednisone—ankylosing spondylitis	0.000138	0.00118	CcSEcCtD
Mitotane—Headache—Prednisone—ankylosing spondylitis	0.000137	0.00118	CcSEcCtD
Mitotane—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000135	0.00115	CcSEcCtD
Mitotane—Asthenia—Methotrexate—ankylosing spondylitis	0.000131	0.00112	CcSEcCtD
Mitotane—Nausea—Prednisone—ankylosing spondylitis	0.00013	0.00111	CcSEcCtD
Mitotane—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000125	0.00107	CcSEcCtD
Mitotane—Dizziness—Methotrexate—ankylosing spondylitis	0.000121	0.00104	CcSEcCtD
Mitotane—Vomiting—Methotrexate—ankylosing spondylitis	0.000117	0.000997	CcSEcCtD
Mitotane—Rash—Methotrexate—ankylosing spondylitis	0.000116	0.000988	CcSEcCtD
Mitotane—Dermatitis—Methotrexate—ankylosing spondylitis	0.000115	0.000987	CcSEcCtD
Mitotane—Headache—Methotrexate—ankylosing spondylitis	0.000115	0.000982	CcSEcCtD
Mitotane—Nausea—Methotrexate—ankylosing spondylitis	0.000109	0.000931	CcSEcCtD
